ESR1 and breast carcinoma: The co-culture of ER+ breast cancer cells with obese ASCs activated many pathways such as leptin, IL6, Notch, and jagged canonical Notch ligand 2 (JAG2), which mediated radiation resistance in ER+ breast cancer cells [83].